ALGRX-4975: Clinical Trials

4 trials of ALGRX-4975, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 31Completed 1

Follow ALGRX-4975: new trials by email Literature Review of ALGRX-4975 trials Research Report on ALGRX-4975

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Tolerability of 4975 in Patients Undergoing Arthroscopic Surgery to Repair the Rotator Cuff of the Shoulder
4975 - Highly purified capsaicin, Placebo - Rotator Cuff Repair of the Shoulder
Phase 2TerminatedAnesiva, Inc.242008-07-012009-05-04
Sensory Function After Wound Instillation of Capsaicin
Capsaicin - Primary Hyperalgesia
CompletedCopenhagen University Hospital, Rigshospitalet422008-01-012008-01-30
Safety and Efficacy Study of 4975 in Patients Undergoing Total Knee Replacement
4975, 15 and 5 mg, Placebo Comparator, 4975 - 5 mg - Total Knee Arthroplasty (Replacement)
Phase 3CompletedAnesiva, Inc.2142007-09-012009-05-04
Efficacy and Safety Study of 4975 in Patients Undergoing Total Hip Replacement
4975, highly purified capsaicin, Placebo - Arthroplasty
Phase 2TerminatedAnesiva, Inc.1182007-09-012009-05-04

Conditions studied

Hyperalgesia (1)  ·  Hypesthesia (1)

Sponsors

Anesiva, Inc. (3)  ·  Copenhagen University Hospital, Rigshospitalet (1)

Countries

United States (2)  ·  Denmark (1)  ·  South Korea (1)

Top investigators

Shaun Comfort, MD (2)  ·  Henrik Kehlet, M.D, Ph. D. (1)  ·  Shaun Comfort, MD, MBA (1)  ·  William Houghton, MD (1)

Results publications

PMID 21971213